Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 10/20 | 0.53 |
| ▸ | PPARG | P37231 | 9/20 | 0.53 |
| ▸ | MAOB | P27338 | 1/20 | 0.48 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.48 |
| ▸ | EGFR | P00533 | 2/20 | 0.47 |
| ▸ | PLAU | P00749 | 2/20 | 0.47 |
| ▸ | PLG | P00747 | 1/20 | 0.47 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.45 |
| ▸ | DBH | P09172 | 1/20 | 0.45 |
| ▸ | DPP4 | P27487 | 1/20 | 0.43 |
| ▸ | HTR2A | P28223 | 1/20 | 0.43 |
| ▸ | HTR2C | P28335 | 1/20 | 0.43 |
| ▸ | PDE1A | P54750 | 1/20 | 0.42 |
| ▸ | PDE1B | Q01064 | 1/20 | 0.42 |
| ▸ | PDE1C | Q14123 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11949599 | 0.84 | DPP4 (0.53) | EPHX2PPARGMAOBSLC2A1EGFR | |
| SCHEMBL16783105 | 0.84 | APP (0.52) | PLAUPLGERBB2 | |
| SCHEMBL3507375 | 0.82 | EGFR (0.62) | EPHX2PPARGMAOBSLC2A1EGFR | |
| SCHEMBL6085951 | 0.82 | EGFR (0.51) | EPHX2PPARGMAOBSLC2A1EGFR | |
| SCHEMBL15701546 | 0.81 | KCNH2 (0.49) | EPHX2PPARGMAOBSLC2A1EGFR | |
| SCHEMBL31258087 | 0.81 | HTR6 (0.55) | EPHX2PPARGMAOBSLC2A1EGFR | |
| SCHEMBL1104768 | 0.81 | HTR6 (0.55) | EPHX2PPARGMAOBSLC2A1EGFR | |
| Ethoxycarbonyl Group SCHEMBL28763762 | 0.79 | EPHX2 (0.47) | EPHX2PPARGMAOBSLC2A1EGFR | |
| SCHEMBL4194376 | 0.76 | IDO1 (0.54) | EPHX2PPARGMAOBSLC2A1EGFR | |
| SCHEMBL9584191 | 0.76 | APP (0.53) | PPARGPLAUPLGERBB2HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2680850-B1 | ALKYNE SUBSTITUTED QUINAZOLINE COMPOUND AND METHODS OF USE | NEWGEN THERAPEUTICS INC (US) | 2018-05-23 | — | — | EP | disclosed |